Clene Inc. (NASDAQ: CLNN) Participates In Three Investor Conferences During May 2024, Promoting CNM-Au8(R) Neuronal ...
(MENAFN- Investor Brand Network ) Clene recently participated in the Mizuho Neuroscience Summit 2024, the Benchmark 2024 Healthcare House Call Virtual Conference, and the Virtual A.G.P. Healthcare Conference CNM-Au8(R) is oral suspension developed to …